Q-Line Biotec IPO GMP Day-3: Grey Market Premium

Track the latest Q-Line Biotech IPO GMP, including Grey Market Premium, Kostak rates, and Subject to Sauda updates as of today. The Q-Line Biotech IPO GMP has become active in the grey market, and investors are closely watching further movement ahead of the IPO process. Stay tuned for regular updates on Q-Line Biotech IPO GMP trends and grey market activity.

Q-Line Biotech IPO touched a high of ₹141 on 21st May, while the lowest GMP recorded was ₹65 on 18th May. The IPO is scheduled to open on May 21, 2026. It is an NSE SME IPO aiming to raise around ₹214 crores. The Q-Line Biotech IPO price band has been fixed at ₹326 to ₹343 per share with a minimum market lot of 800 shares.

Q-Line Biotech IPO GMP Live Rates day by day with Kostak rates.

Date	IPO GMP	GMP Trend	Gain
25 May	₹125		36.44%
23 May	₹130		37.90%
22 May	₹120		34.99%
21 May	₹125		36.44%
20 May	₹110		32.07%
19 May	₹97		28.28%
18 May	₹65		18.95%

Company overview

Q-Line Biotech is an Indian In-Vitro Diagnostics (IVD) company founded in 2008 with its headquarters located in Lucknow, Uttar Pradesh. The company is engaged in the manufacturing, development, and supply of diagnostic products, laboratory equipment, rapid testing solutions, and pathology instruments for the healthcare industry. Under the “Make in India” initiative, Q-Line Biotech focuses on domestic production of advanced healthcare products including hematology reagents, magnetic beads, gold nanoparticles, ELISA kits, urine testing strips, and multiple biochemistry diagnostic solutions.

The company caters to hospitals, diagnostic centers, medical institutions, pathology laboratories, and healthcare organizations across India and international markets. Q-Line Biotech has expanded its global footprint by exporting products to over 50 countries. The company maintains strong quality standards and operates with certifications such as ISO 9001:2015 and ISO 13485:2016. Through continuous innovation, modern manufacturing practices, and a focus on accessible healthcare diagnostics, Q-Line Biotech continues to strengthen its presence in the medical diagnostics and laboratory solutions sector.